DK1202746T3 - NSAID- og EGFR-kinaseinhibitorerholdigt præparat til behandling eller inhibering af colonpolypper og colorektal cancer - Google Patents
NSAID- og EGFR-kinaseinhibitorerholdigt præparat til behandling eller inhibering af colonpolypper og colorektal cancerInfo
- Publication number
- DK1202746T3 DK1202746T3 DK00950930T DK00950930T DK1202746T3 DK 1202746 T3 DK1202746 T3 DK 1202746T3 DK 00950930 T DK00950930 T DK 00950930T DK 00950930 T DK00950930 T DK 00950930T DK 1202746 T3 DK1202746 T3 DK 1202746T3
- Authority
- DK
- Denmark
- Prior art keywords
- nsaid
- inhibition
- treatment
- colorectal cancer
- kinase inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US37326199A | 1999-08-12 | 1999-08-12 |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1202746T3 true DK1202746T3 (da) | 2007-01-02 |
Family
ID=23471660
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00950930T DK1202746T3 (da) | 1999-08-12 | 2000-08-02 | NSAID- og EGFR-kinaseinhibitorerholdigt præparat til behandling eller inhibering af colonpolypper og colorektal cancer |
Country Status (24)
Country | Link |
---|---|
EP (1) | EP1202746B1 (da) |
JP (1) | JP2003507342A (da) |
KR (1) | KR20020018201A (da) |
CN (1) | CN1229142C (da) |
AR (1) | AR029763A1 (da) |
AT (1) | ATE341341T1 (da) |
AU (1) | AU783116B2 (da) |
BR (1) | BR0013219A (da) |
CA (1) | CA2380904C (da) |
CZ (1) | CZ2002474A3 (da) |
DE (1) | DE60031127T2 (da) |
DK (1) | DK1202746T3 (da) |
EA (1) | EA006876B1 (da) |
ES (1) | ES2272305T3 (da) |
HK (1) | HK1042244A1 (da) |
HU (1) | HUP0203162A3 (da) |
IL (1) | IL147913A0 (da) |
MX (1) | MXPA02001448A (da) |
NO (1) | NO20020663L (da) |
NZ (1) | NZ517120A (da) |
PL (1) | PL353267A1 (da) |
PT (1) | PT1202746E (da) |
WO (1) | WO2001012227A1 (da) |
ZA (1) | ZA200201156B (da) |
Families Citing this family (33)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040127470A1 (en) * | 1998-12-23 | 2004-07-01 | Pharmacia Corporation | Methods and compositions for the prevention or treatment of neoplasia comprising a Cox-2 inhibitor in combination with an epidermal growth factor receptor antagonist |
BR0109165A (pt) * | 2000-03-13 | 2003-04-22 | American Cyanamid Co | Método de tratamento de pólipos colÈnicos |
US6384051B1 (en) | 2000-03-13 | 2002-05-07 | American Cyanamid Company | Method of treating or inhibiting colonic polyps |
WO2003000705A1 (en) | 2001-06-21 | 2003-01-03 | Ariad Pharmaceuticals, Inc. | Novel quinolines and uses thereof |
JP4326328B2 (ja) | 2001-07-16 | 2009-09-02 | アストラゼネカ アクチボラグ | キノリン誘導体及びそれらのチロシンキナーゼ阻害薬としての使用 |
BR0213486A (pt) * | 2001-10-25 | 2005-05-10 | Novartis Ag | Combinações que compreendem um inibidor seletivo de ciclooxigenase-2 |
US6924285B2 (en) | 2002-03-30 | 2005-08-02 | Boehringer Ingelheim Pharma Gmbh & Co. | Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them |
AU2003250701A1 (en) | 2002-07-31 | 2004-02-16 | Wayne R. Danter | Protein tyrosine kinase inhibitors |
CA2542007C (en) | 2002-10-09 | 2010-06-29 | Wayne R. Danter | Protein tyrosine kinase inhibitors |
WO2004046386A1 (en) * | 2002-11-15 | 2004-06-03 | Genomic Health, Inc. | Gene expression profiling of egfr positive cancer |
US8309562B2 (en) | 2003-07-03 | 2012-11-13 | Myrexis, Inc. | Compounds and therapeutical use thereof |
TW200529846A (en) | 2004-02-20 | 2005-09-16 | Wyeth Corp | 3-quinolinecarbonitrile protein kinase inhibitors |
EP2168968B1 (en) | 2004-04-02 | 2017-08-23 | OSI Pharmaceuticals, LLC | 6,6-bicyclic ring substituted heterobicyclic protein kinase inhibitors |
UA85706C2 (en) | 2004-05-06 | 2009-02-25 | Уорнер-Ламберт Компани Ллси | 4-phenylaminoquinazolin-6-yl amides |
AU2005249206A1 (en) | 2004-06-03 | 2005-12-15 | F. Hoffmann-La Roche Ag | Treatment with cisplatin and an EGFR-inhibitor |
EP1833482A4 (en) | 2005-01-03 | 2011-02-16 | Myriad Genetics Inc | COMPOUNDS AND ITS THERAPEUTIC USE |
US8258145B2 (en) | 2005-01-03 | 2012-09-04 | Myrexis, Inc. | Method of treating brain cancer |
US8575164B2 (en) | 2005-12-19 | 2013-11-05 | OSI Pharmaceuticals, LLC | Combination cancer therapy |
EP1921070A1 (de) | 2006-11-10 | 2008-05-14 | Boehringer Ingelheim Pharma GmbH & Co. KG | Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstelllung |
EP2118075A1 (de) | 2007-02-06 | 2009-11-18 | Boehringer Ingelheim International GmbH | Bicyclische heterocyclen, diese verbindungen enthaltende arzneimittel, deren verwendung und verfahren zu ihrer herstellung |
EP2225226B1 (en) | 2007-12-26 | 2016-08-17 | Critical Outcome Technologies, Inc. | Compounds and their use in a method for treatment of cancer |
JP5336516B2 (ja) | 2008-02-07 | 2013-11-06 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | スピロ環式複素環化合物、該化合物を含む医薬品、その使用及びその製造方法 |
ES2444128T3 (es) | 2008-05-13 | 2014-02-24 | Astrazeneca Ab | Nueva SAL-554 |
JP2011520970A (ja) | 2008-05-19 | 2011-07-21 | オーエスアイ・フアーマスーテイカルズ・インコーポレーテツド | 置換されたイミダゾピラジン類およびイミダゾトリアジン類 |
CA2999321A1 (en) | 2008-07-17 | 2010-01-21 | Critical Outcome Technologies Inc. | Thiosemicarbazone inhibitor compounds and cancer treatment methods |
US8648191B2 (en) | 2008-08-08 | 2014-02-11 | Boehringer Ingelheim International Gmbh | Cyclohexyloxy substituted heterocycles, pharmaceutical compositions containing these compounds and processes for preparing them |
PL387312A1 (pl) * | 2009-02-19 | 2010-08-30 | Farma-Projekt Spółka Z Ograniczoną Odpowiedzialnością | Zastosowanie sulindaku i/lub jego metabolitu we wspomagającym leczeniu raka jelita grubego u ludzi |
EP2408479A1 (en) | 2009-03-18 | 2012-01-25 | OSI Pharmaceuticals, LLC | Combination cancer therapy comprising administration of an egfr inhibitor and an igf-1r inhibitor |
CA2752826A1 (en) | 2009-04-20 | 2010-10-28 | OSI Pharmaceuticals, LLC | Preparation of c-pyrazine-methylamines |
EP2552915B1 (en) | 2010-04-01 | 2017-07-19 | Critical Outcome Technologies Inc. | Compounds for the treatment of hiv |
AU2010363329A1 (en) | 2010-11-07 | 2013-05-09 | Targegen, Inc. | Compositions and methods for treating myelofibrosis |
WO2012129145A1 (en) | 2011-03-18 | 2012-09-27 | OSI Pharmaceuticals, LLC | Nscle combination therapy |
RU2606114C2 (ru) * | 2011-06-01 | 2017-01-10 | Джейнус Байотерапьютикс, Инк. | Новые модуляторы иммунной системы |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6391872B1 (en) * | 1997-11-04 | 2002-05-21 | Pfizer Inc | Indazole bioisostere replacement of catechol in therapeutically active compounds |
CN1278176A (zh) * | 1997-11-06 | 2000-12-27 | 美国氰胺公司 | 喹唑啉衍生物作为用于治疗结肠息肉的酪氨酸激酶抑制剂的应用 |
-
2000
- 2000-08-02 AT AT00950930T patent/ATE341341T1/de not_active IP Right Cessation
- 2000-08-02 WO PCT/US2000/021021 patent/WO2001012227A1/en active IP Right Grant
- 2000-08-02 EP EP00950930A patent/EP1202746B1/en not_active Expired - Lifetime
- 2000-08-02 CZ CZ2002474A patent/CZ2002474A3/cs unknown
- 2000-08-02 HU HU0203162A patent/HUP0203162A3/hu unknown
- 2000-08-02 DE DE60031127T patent/DE60031127T2/de not_active Expired - Lifetime
- 2000-08-02 PL PL00353267A patent/PL353267A1/xx not_active Application Discontinuation
- 2000-08-02 PT PT00950930T patent/PT1202746E/pt unknown
- 2000-08-02 BR BR0013219-5A patent/BR0013219A/pt not_active IP Right Cessation
- 2000-08-02 CN CNB008117977A patent/CN1229142C/zh not_active Expired - Fee Related
- 2000-08-02 KR KR1020027001817A patent/KR20020018201A/ko not_active Application Discontinuation
- 2000-08-02 MX MXPA02001448A patent/MXPA02001448A/es active IP Right Grant
- 2000-08-02 JP JP2001516570A patent/JP2003507342A/ja active Pending
- 2000-08-02 IL IL14791300A patent/IL147913A0/xx unknown
- 2000-08-02 AU AU63959/00A patent/AU783116B2/en not_active Ceased
- 2000-08-02 EA EA200200246A patent/EA006876B1/ru not_active IP Right Cessation
- 2000-08-02 CA CA002380904A patent/CA2380904C/en not_active Expired - Fee Related
- 2000-08-02 NZ NZ517120A patent/NZ517120A/en unknown
- 2000-08-02 ES ES00950930T patent/ES2272305T3/es not_active Expired - Lifetime
- 2000-08-02 DK DK00950930T patent/DK1202746T3/da active
- 2000-08-11 AR ARP000104159A patent/AR029763A1/es not_active Application Discontinuation
-
2002
- 2002-02-11 NO NO20020663A patent/NO20020663L/no not_active Application Discontinuation
- 2002-02-11 ZA ZA200201156A patent/ZA200201156B/en unknown
- 2002-05-29 HK HK02104004.4A patent/HK1042244A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
ATE341341T1 (de) | 2006-10-15 |
MXPA02001448A (es) | 2002-07-02 |
WO2001012227A1 (en) | 2001-02-22 |
JP2003507342A (ja) | 2003-02-25 |
DE60031127T2 (de) | 2007-02-01 |
HUP0203162A2 (hu) | 2003-01-28 |
KR20020018201A (ko) | 2002-03-07 |
EA006876B1 (ru) | 2006-04-28 |
CA2380904C (en) | 2009-02-10 |
BR0013219A (pt) | 2002-04-23 |
NO20020663L (no) | 2002-04-09 |
ZA200201156B (en) | 2003-05-12 |
IL147913A0 (en) | 2002-08-14 |
DE60031127D1 (de) | 2006-11-16 |
HUP0203162A3 (en) | 2006-07-28 |
PT1202746E (pt) | 2007-01-31 |
CZ2002474A3 (cs) | 2003-02-12 |
HK1042244A1 (zh) | 2002-08-09 |
AU783116B2 (en) | 2005-09-29 |
CA2380904A1 (en) | 2001-02-22 |
CN1370080A (zh) | 2002-09-18 |
AR029763A1 (es) | 2003-07-16 |
EP1202746B1 (en) | 2006-10-04 |
NO20020663D0 (no) | 2002-02-11 |
ES2272305T3 (es) | 2007-05-01 |
NZ517120A (en) | 2004-10-29 |
AU6395900A (en) | 2001-03-13 |
PL353267A1 (en) | 2003-11-03 |
EP1202746A1 (en) | 2002-05-08 |
CN1229142C (zh) | 2005-11-30 |
EA200200246A1 (ru) | 2002-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1202746T3 (da) | NSAID- og EGFR-kinaseinhibitorerholdigt præparat til behandling eller inhibering af colonpolypper og colorektal cancer | |
DK1292594T3 (da) | Quinazolinderivater til behandling af tumorer | |
NO20002166D0 (no) | Anvendelse av quinazolinderivater som tyrosinkinaseinhibitorer for behandling av kolonpolypper | |
DK1263503T3 (da) | Anvendelse af cyanoquinoliner til behandling erller inhibering af tyktarmspolypper | |
NO20052760D0 (no) | Fremgangsmate for behandling av kreft og beslektede fremgangsmater. | |
DK1144395T3 (da) | 2-amino-benzoxazinon-derivater til behandling af fedme | |
DK1165078T3 (da) | Fremgangsmåder til induktion af cancercelledöd og tumorregression | |
NO20021820L (no) | Tyrosinkinaseinhibitorer | |
DK1576132T3 (da) | Nukleinsyrer benævnt 273p4b7 og anvendelse heraf til detektering af cancer | |
NO20012583D0 (no) | Quinoliner og quinoksalinforbindelser som PDGF-R- og/eller LCK-tyrosinkinase-inhibitorer | |
IS7233A (is) | Kínasólín afleiður til meðhöndlunar á afbrigðilegum frumuvexti | |
ATE412070T1 (de) | Prognose von kolorektalem krebs | |
NO20033635D0 (no) | Pyrimidinderivater for inhibering av celle-formering | |
IS7137A (is) | Samsett meðferð til meðhöndlunar á krabbameini | |
NO20015516L (no) | Preparater og anvendelser av ET743 for behandling av kreft | |
DK1432417T3 (da) | Substituerede imidazolforbindelser og deres anvendelse til behandling af cancer | |
NO20022245D0 (no) | Onkolyttiske kombinasjoner for behandling av cancer | |
NO20020358L (no) | Anvendelse av etodolac til behandling av kreft | |
NO20034350D0 (no) | Optisk avbilding av kolorektal kreft | |
AU2002311859A1 (en) | Compositions and methods for treating colorectal polyps and cancer | |
DK1239862T3 (da) | Farmaceutisk præparat indeholdende cytostatika og eletronacceptorer til behandling af kræft | |
DK1512758T3 (da) | Prognose af colorektal cancer | |
DK1330442T3 (da) | Phthalazinon-derivativer | |
DK1567524T3 (da) | Thia-epothilonderivater til behandling af cancer | |
DK1140147T3 (da) | hCG-terapi til behandling af metastatisk brystcancer |